Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vrijmoeth

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|December 11, 2014
[Challenging behaviour in patients with intellectual disability]Gerda M de Kuijper, P Vrijmoeth
Nederlands Tijdschrift Voor Geneeskunde|August 30, 1997
[Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum]P Vrijmoeth, R A Heijtink, H Schreuder, et al.
Journal of Intellectual Disability Research : JIDR|January 5, 2019
Is risperidone effective in reducing challenging behaviours in individuals with intellectual disabilities after 1 year or longer use? A placebo-controlled, randomised, double-blind discontinuation studyL Ramerman, G de Kuijper, T Scheers, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|December 11, 2014
[Challenging behaviour in patients with intellectual disability]Gerda M de Kuijper, P Vrijmoeth
Nederlands Tijdschrift Voor Geneeskunde|August 30, 1997
[Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum]P Vrijmoeth, R A Heijtink, H Schreuder, et al.
Journal of Intellectual Disability Research : JIDR|January 5, 2019
Is risperidone effective in reducing challenging behaviours in individuals with intellectual disabilities after 1 year or longer use? A placebo-controlled, randomised, double-blind discontinuation studyL Ramerman, G de Kuijper, T Scheers, et al.
Pageof 1